CL2013002034A1 - Composicion que comprende al menos un analogo de prostaciclina; su uso para tratar una enfermedad de la medula osea; y metodo para mejorar el injerto de celulas madre hematopoyeticas. - Google Patents
Composicion que comprende al menos un analogo de prostaciclina; su uso para tratar una enfermedad de la medula osea; y metodo para mejorar el injerto de celulas madre hematopoyeticas.Info
- Publication number
- CL2013002034A1 CL2013002034A1 CL2013002034A CL2013002034A CL2013002034A1 CL 2013002034 A1 CL2013002034 A1 CL 2013002034A1 CL 2013002034 A CL2013002034 A CL 2013002034A CL 2013002034 A CL2013002034 A CL 2013002034A CL 2013002034 A1 CL2013002034 A1 CL 2013002034A1
- Authority
- CL
- Chile
- Prior art keywords
- treat
- composition
- stem cell
- bone marrow
- hematopoietic stem
- Prior art date
Links
- 208000015322 bone marrow disease Diseases 0.000 title 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 title 1
- 150000003815 prostacyclins Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11150835 | 2011-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013002034A1 true CL2013002034A1 (es) | 2014-03-21 |
Family
ID=44146841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013002034A CL2013002034A1 (es) | 2011-01-13 | 2013-07-12 | Composicion que comprende al menos un analogo de prostaciclina; su uso para tratar una enfermedad de la medula osea; y metodo para mejorar el injerto de celulas madre hematopoyeticas. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10213464B2 (https=) |
| EP (1) | EP2663313B1 (https=) |
| JP (2) | JP6110309B2 (https=) |
| KR (1) | KR101950526B1 (https=) |
| CN (1) | CN103379907B (https=) |
| AU (1) | AU2012206517B2 (https=) |
| BR (1) | BR112013017878B1 (https=) |
| CA (1) | CA2824113C (https=) |
| CL (1) | CL2013002034A1 (https=) |
| DK (1) | DK2663313T3 (https=) |
| EA (1) | EA033717B1 (https=) |
| ES (1) | ES2693622T3 (https=) |
| IL (1) | IL227331A (https=) |
| PL (1) | PL2663313T3 (https=) |
| PT (1) | PT2663313T (https=) |
| SG (1) | SG191908A1 (https=) |
| UA (1) | UA113284C2 (https=) |
| WO (1) | WO2012095511A1 (https=) |
| ZA (1) | ZA201304743B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2879682B1 (en) * | 2012-08-01 | 2018-03-21 | United Therapeutics Corporation | Treatment of pulmonary arterial hypertension with mesenchymal stem cells |
| EP3712142B1 (en) | 2013-01-11 | 2022-07-06 | Corsair Pharma, Inc. | Prodrugs of treprostinil |
| US9505737B2 (en) | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
| AU2015217142B2 (en) * | 2014-02-12 | 2020-04-09 | 7 Hills Pharma LLC | Compositions and methods to improve the homing and grafting of hematopoetic stem cells |
| CA2946747A1 (en) * | 2014-04-23 | 2015-10-29 | Texas Heart Institute | Methods of enhancing stem cell engraftment |
| US10226465B2 (en) * | 2015-01-27 | 2019-03-12 | Scipharm Sàrl | Composition for use in increasing engraftment efficacy of haematopoetic stem cells after transplantation |
| US9394227B1 (en) | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| IL262720B2 (en) | 2016-05-05 | 2024-06-01 | Liquidia Tech Inc | Dry powder treprostinil for the treatment of pulmonary hypertension |
| CN109727671B (zh) * | 2018-12-28 | 2021-07-09 | 广东省心血管病研究所 | 一种鉴定造血干细胞移植术效果的信息分析系统及方法 |
| WO2025172541A1 (en) | 2024-02-15 | 2025-08-21 | Aop Orphan Pharmaceuticals Gmbh | New composition for improvement of bone marrow reconstitution and peripheral recovery of neutrophil and platelet counts |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6441245B1 (en) | 1997-10-24 | 2002-08-27 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
| US6242482B1 (en) * | 2000-06-05 | 2001-06-05 | United Therapeutics Corporation | Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure |
| US8696564B2 (en) | 2004-07-09 | 2014-04-15 | Cardiac Pacemakers, Inc. | Implantable sensor with biocompatible coating for controlling or inhibiting tissue growth |
| US20070065414A1 (en) * | 2005-09-16 | 2007-03-22 | Boston Scientific Scimed, Inc. | Enhanced delivery of cells |
| RU2425876C2 (ru) | 2006-03-24 | 2011-08-10 | Чилдрен'З Медикал Сентер Корпорейшн | Способ модулирования роста гематопоэтических стволовых клеток |
| EP3824885A1 (en) * | 2006-10-20 | 2021-05-26 | Children's Medical Center Corporation | Method to enhance tissue regeneration |
| US8575175B2 (en) * | 2008-07-23 | 2013-11-05 | Toray Industries, Inc. | Therapeutic agent for chronic renal failure |
| CN102164487A (zh) * | 2008-09-25 | 2011-08-24 | 阿拉迪姆公司 | 曲前列素的深肺部递送 |
| CN108379292A (zh) | 2008-11-06 | 2018-08-10 | 印第安纳大学研究与技术公司 | 增强造血干细胞植入过程的材料和方法 |
| WO2010108028A2 (en) | 2009-03-19 | 2010-09-23 | Fate Therapeutics, Inc. | Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same |
| RS53234B (sr) * | 2009-08-07 | 2014-08-29 | Scipharm Sàrl | Kompozicija za lečenje cistične fibroze |
-
2012
- 2012-01-13 US US13/979,332 patent/US10213464B2/en active Active
- 2012-01-13 AU AU2012206517A patent/AU2012206517B2/en active Active
- 2012-01-13 EP EP12700137.8A patent/EP2663313B1/en active Active
- 2012-01-13 ES ES12700137.8T patent/ES2693622T3/es active Active
- 2012-01-13 DK DK12700137.8T patent/DK2663313T3/en active
- 2012-01-13 SG SG2013052790A patent/SG191908A1/en unknown
- 2012-01-13 WO PCT/EP2012/050484 patent/WO2012095511A1/en not_active Ceased
- 2012-01-13 EA EA201300817A patent/EA033717B1/ru not_active IP Right Cessation
- 2012-01-13 KR KR1020137021164A patent/KR101950526B1/ko active Active
- 2012-01-13 BR BR112013017878-7A patent/BR112013017878B1/pt active IP Right Grant
- 2012-01-13 PL PL12700137T patent/PL2663313T3/pl unknown
- 2012-01-13 UA UAA201309882A patent/UA113284C2/uk unknown
- 2012-01-13 CA CA2824113A patent/CA2824113C/en active Active
- 2012-01-13 PT PT12700137T patent/PT2663313T/pt unknown
- 2012-01-13 CN CN201280005272.XA patent/CN103379907B/zh active Active
- 2012-01-13 JP JP2013548848A patent/JP6110309B2/ja active Active
-
2013
- 2013-06-25 ZA ZA2013/04743A patent/ZA201304743B/en unknown
- 2013-07-04 IL IL227331A patent/IL227331A/en active IP Right Grant
- 2013-07-12 CL CL2013002034A patent/CL2013002034A1/es unknown
-
2016
- 2016-10-19 JP JP2016204970A patent/JP2017046707A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2663313A1 (en) | 2013-11-20 |
| JP2017046707A (ja) | 2017-03-09 |
| CN103379907B (zh) | 2018-01-09 |
| ES2693622T3 (es) | 2018-12-13 |
| JP2014507409A (ja) | 2014-03-27 |
| ZA201304743B (en) | 2014-09-25 |
| DK2663313T3 (en) | 2018-11-26 |
| UA113284C2 (xx) | 2017-01-10 |
| NZ612450A (en) | 2015-03-27 |
| BR112013017878A8 (pt) | 2018-01-09 |
| US20130344038A1 (en) | 2013-12-26 |
| AU2012206517A1 (en) | 2013-08-01 |
| IL227331A0 (en) | 2013-09-30 |
| US10213464B2 (en) | 2019-02-26 |
| IL227331A (en) | 2017-12-31 |
| EA201300817A1 (ru) | 2013-11-29 |
| SG191908A1 (en) | 2013-08-30 |
| KR101950526B1 (ko) | 2019-02-20 |
| PT2663313T (pt) | 2018-10-23 |
| BR112013017878A2 (https=) | 2017-08-15 |
| CN103379907A (zh) | 2013-10-30 |
| JP6110309B2 (ja) | 2017-04-05 |
| KR20140005956A (ko) | 2014-01-15 |
| PL2663313T3 (pl) | 2019-01-31 |
| EP2663313B1 (en) | 2018-08-08 |
| EA033717B1 (ru) | 2019-11-19 |
| WO2012095511A1 (en) | 2012-07-19 |
| AU2012206517B2 (en) | 2016-12-01 |
| CA2824113A1 (en) | 2012-07-19 |
| BR112013017878B1 (pt) | 2021-08-31 |
| CA2824113C (en) | 2020-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2013002034A1 (es) | Composicion que comprende al menos un analogo de prostaciclina; su uso para tratar una enfermedad de la medula osea; y metodo para mejorar el injerto de celulas madre hematopoyeticas. | |
| BR112014005400A2 (pt) | método para aumentar o crescimento de uma planta, e, composição | |
| BRPI1010775A2 (pt) | composição, método para preparar uma composição, e, uso de uma composição. | |
| BR112012013096A2 (pt) | mistura agroquímica para aumentar a saúde de uma planta, composição pesticida, método para aperfeiçoamento da saúde de uma planta e uso de uma planta | |
| CL2014001162A1 (es) | Inoculantes microbianos que comprenden lactobacillus; composicion fertilizante que comprenden los mismos; metodo para aumentar crecimiento y/o la productividad de plantas. | |
| BRPI1013771A2 (pt) | "células-tronco mesenquimais projetadas e método de uso das mesmas para tratar tumores." | |
| NI201001031A (es) | Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo. | |
| WO2013070881A8 (en) | Method for elimination of space through tissue approximation | |
| CR20120357A (es) | Composición que comprende un pesticida y un alcoxilato de 2-propilheptilamina | |
| CL2014000254A1 (es) | Hormona de crecimiento de accion prolongada y metodo para producir la misma | |
| BR112012030304A2 (pt) | método para aumentar a saúde de uma planta e uso de uma mistura | |
| GT201200276A (es) | Combinaciones de compuestos activos | |
| CL2014000759A1 (es) | Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor que comprende al menos un ácido graso poliinsaturado de cadena larga (lc-pufa), al menos un probiótico y una mezcla de oligosacáridos; uso de la composición. | |
| BR112013004456A2 (pt) | composição para tratamento de planta, e, método para o tratamento de plantas | |
| BR112013030321A2 (pt) | composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv. | |
| BR112014006917A2 (pt) | método para intensificar o crescimento das plantas | |
| BR112012029606A2 (pt) | formulação, método para a fabricação de uma fomulação, método de tratamento de uma planta e uso de uma formulação | |
| BR112012027145A2 (pt) | emulsão, composição de uso final e método para tratar uma condição cutânea | |
| CL2013000735A1 (es) | Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para el tratamiento de enfermedades y condiciones de la piel, tales como rosacea, daño solar cronico, psoriasis, entre otras; kit farmaceutico. | |
| CL2013001129A1 (es) | Composicion que comprende una celula madre gbm6-ad de glioblastoma purificada; metodo de generacion de anticuerpos especificos para gbm6-ad; dicho anticuerpo; metodo para producir una vacuna de celulas dendriticas; y su uso para el tratamiento de cancer. | |
| CL2014001719A1 (es) | Metodo para tratar la perdida osea alveolar que comprende anticuerpo antiesclerostina. | |
| CL2013003191A1 (es) | Uso de compuestos derivados de acidos carboxilicos de trifluorometil-benzotiofenos, en méetodos para promover el crecimiento de plantas. | |
| BR112013011817A2 (pt) | ''método para produzir uma cepa de saccharomyces cerevisiae,cepa de saccharomyces cerevisiae e uso de uma cepa' | |
| BR112014031169A2 (pt) | composição para uso como inóculo de silagem, método para tratar material de planta, método de aprimorar o desempenho de carne e de leite, cepa de levedura | |
| CL2013000237A1 (es) | Composicion farmaceutica que comprende un sirna dirigido a vegfa; y metodo para disminuir la expresion de vegfa in vivo. |